• Go to navigation
  • Go to content
Welcome to Zomig.info!

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca
  • Zomig
  • Zomig Rapimelt
  • Zomig Nasal Spray

Main navigation

  • Home
  • Is it Migraine?
  • Learn About Migraine
    • Migraine Aetiology
    • Migraine Epidemiology
      • Economic Impact of Migraine
  • Treating Migraine
  • Help For Your Migraine Patients
  • Scientific Opinions
  • Learn about Zomig
  • eDetailing
  • Prescribing Information
  • Migraine Glossary and Useful Links
  • References
  • About AstraZeneca
  • Sitemap

You are here

  • Home
  • Learn About Migraine
  • Migraine Epidemiology

Migraine affects more than 1 in 10 people, many in the busiest years of their lives

Recent estimates suggest that migraine affects approximately 11% of the world's adult population. [2]

Most migraineurs experience their first migraine attack during childhood or as an adolescent, but the onset of first migraine can sometimes occur during adultlife. The prevalence of migraine is higher in females than males. [24-26]

  • After puberty, the prevalence of migraine increases much more rapidly in females.
  • By 20 years of age, migraine is twice as common in women as in men.
  • The prevalence of migraine continues to increase during the years of menstruation, and the female-to-male ratio peaks at 3.3 to 1 between the ages of 42 and 44 years.

 Prevalence of migraines

  • Migraine can affect people at any age, but it is most common between the ages of 25 and 55 years, when work and family commitments are maximal.

Various surveys have been carried out to estimate the prevalence of migraine indifferent countries. The outcomes of these surveys are presented below. [20,24,27- 41]

 Regional Prevalence of migraines



Research suggests that the prevalence of migraine is higher in white Americans than in African Americans [24,42] or Asian Americans, [42] and similar trends in terms of ethnicity have been observed in other countries. Such differences in prevalence may be due to methodological shortcomings or to cultural and environmental factors. In addition, genetic susceptibility to migraine may also differ between countries.

Previously, it was considered that migraine was correlated with high socioeconomic status and intelligence. However, this observation is likely due to intelligence and social class predicting those patients more likely to consult a physician about their condition, rather than an actual predisposition to migraine. [43]

Back to top

Not signed in



  • Register
  • Forgotten password?

Page tools

  • Print
  • Bookmark this page

Clinical Product Summary

  • Zomig Nasal Spray
  • Zomig Rapimelt

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2008